Brazil’s World Cup was the biggest social media event on record involving 350 million Facebook Inc (NASDAQ FB) users worldwide, the company claimed today, as Facebook makes strides into the so-called “real-time” market dominated by Twitter. People increasingly are using social networking to comment on global events seen on television, like the month-long soccer tournament…
In light of the recent European court ruling, Google (NASDAQ: GOOG) has started removing some search results in the European Union. This was as a result of people requesting for the “right to be forgotten”. Google has received more than 41,000 requests, and each request is being handled individually and assessed in a timely manner….
Recently, Apple Inc. (NASDAQ:AAPL) took a softer approach toward its policy on virtual currency by allowing Bitcoin wallets and in-app Bitcoin payments. And now, to take advantage of the currency, the apps facilitating Bitcoin are live in the App Store. According to Coindesk, Coin Pocket is the first Bitcoin app for iOS to re-enter the…
Apple Inc (NASDAQ AAPL) is one of the 26 businesses which have joined the government’s new SupplierPay initiative. The program is similar to the already existing “QuickPay” initiative, which makes sure federal employers pay contractors in a reasonable amount of time. The “SupplierPay” program, the White House says, is intended to be “private-sector counterpart” to…
Let us take a look at two promising stocks: Nuance Comm Inc (NASDAQ NUAN) & Cadence Systems (NASDAQ CDNS). Both have seen seemingly different fortunes in the recent times. While Nuance struggles due to takeover speculations, Cadence has been performing strongly. Cadence Design Systems, Inc. (NASDAQ:CDNS) a leader in global electronic design innovation, announced that…
Off late, Biotech stocks have seen some volatility. Here we look at two promising stocks: Abbvie (NYSE ABBV) and MannKind (NASDAQ MNKD). The two stocks have their fortunes at the opposite end of the spectrum. We take a look at what the future holds for the two stocks. Despite three rejections so far, AbbVie is…
